Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. JCI Insight. 2021 09 08; 6(17).
View in:
PubMed
subject areas
Administration, Oral
Biopsy
Cell Line, Tumor
Dose-Response Relationship, Drug
Female
Gene Expression Regulation, Neoplastic
Humans
Hypoglycemic Agents
Leukoplakia, Oral
Male
Metformin
Middle Aged
Mouth Mucosa
Precancerous Conditions
RNA, Neoplasm
Signal Transduction
Single-Blind Method
TOR Serine-Threonine Kinases
authors with profiles
Ezra Cohen